J.W. Cole Advisors, Inc. Geron Corp Transaction History
J.W. Cole Advisors, Inc.
- $4.58 Billion
- Q2 2025
A detailed history of J.W. Cole Advisors, Inc. transactions in Geron Corp stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 16,230 shares of GERN stock, worth $20,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,230
Previous 16,230
-0.0%
Holding current value
$20,125
Previous $25,000
12.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GERN
# of Institutions
286Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$74.9 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$57.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$53.3 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$44.2 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$33.8 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $468M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...